Esophageal Carcinoma Clinical Trials

80 clinical trials for Esophageal Carcinoma across international registries, including 22 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Vanguard Study: Testing a New Way to Screen for Cancer — RECRUITING · NA
• The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer — RECRUITING
• Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays — RECRUITING · NA
• Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy — RECRUITING
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy — RECRUITING
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program — RECRUITING · PHASE2
• Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal) — RECRUITING · NA
• Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer — RECRUITING · PHASE2
• Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma — RECRUITING · PHASE2
• CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC — RECRUITING · PHASE3
• Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers — RECRUITING · NA
• PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial — RECRUITING · NA
• TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC — RECRUITING · PHASE3
• PET-imaging of Two Vartumabs in Patients With Solid Tumors — RECRUITING · PHASE1
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection — RECRUITING · PHASE1
• Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer — RECRUITING · PHASE2
• Adaptive Neoadjuvant Therapy for Esophageal Cancer — RECRUITING · NA
• Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma — RECRUITING · PHASE1
• Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age — RECRUITING · PHASE2
• Minimally Residual of Esophageal Cancer 001 — RECRUITING
• Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . — RECRUITING · NA
• Chemoradiation in combination with trastuzumab and pertuzumab in operable esophageal carcinoma — COMPLETED · PHASE2
• 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer — TERMINATED
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction — ACTIVE_NOT_RECRUITING · PHASE1
• Yoga Program for Improving the Quality of Life in Couples Coping With Cancer — ACTIVE_NOT_RECRUITING · NA
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• National Cancer Institute "Cancer Moonshot Biobank" — ACTIVE_NOT_RECRUITING
• Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer — ACTIVE_NOT_RECRUITING
• Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19 — COMPLETED · NA
• Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer — COMPLETED · PHASE2
• A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors — COMPLETED · PHASE1
• Influence of acute physical activity on the NK-cell cytotoxicity of esophageal cancer patients — OTHER
• Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer — COMPLETED
• Induction Chemotherapy for Locally Advanced Esophageal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues — ACTIVE_NOT_RECRUITING · PHASE1
• Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age — COMPLETED · PHASE2
• Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study — NOT_YET_RECRUITING · PHASE1
• Defining Musical Toxicity and Its Effect on Patient Well-being — WITHDRAWN
• The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC） — ACTIVE_NOT_RECRUITING
• Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma — COMPLETED · NA
• Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC) — NOT_YET_RECRUITING · PHASE2
• A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer — TERMINATED
• Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) — OTHER · PHASE2
• Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer — COMPLETED · NA
• Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer — COMPLETED · PHASE3
• Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer — OTHER
• Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma — OTHER · PHASE2
• Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study — COMPLETED · PHASE3

Refine this search